Effect of Caudal Block on Urethrocutaneous Fistula After Distal Hypospadias Repair

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age6-60
SponsorSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

About this trial

Hypospadias is one of the most common congenital urogenital anomalies in males, occurring in approximately 1 in every 200-300 male births. It is characterized by abnormal positioning of the urethral meatus on the ventral surface of the penis. Surgical repair is the standard treatment; however, urethrocutaneous fistula formation remains one of the most frequent and clinically significant postoperative complications, potentially requiring reoperation and causing considerable distress to both the patient and the family.

Caudal nerve block is a widely used regional anesthesia technique in pediatric lower abdominal and genitourinary surgery, valued for its high analgesic efficacy, relative ease of application, and low complication profile. However, emerging evidence suggests that caudal block may be associated with an increased incidence of postoperative complications following hypospadias repair, including fistula formation and wound edema. Notably, Kundra et al. (2012) reported a fistula rate of 19.2% in patients who received caudal block, compared to 0% in those who received penile block, raising important questions about the routine use of caudal block in hypospadias surgery.

This prospective, multicenter, randomized controlled trial aims to evaluate the effect of caudal block on the incidence of urethrocutaneous fistula following distal hypospadias repair. A total of 80 male patients aged 6-60 months will be randomized 1:1 to either receive general anesthesia with caudal block or general anesthesia alone. The primary outcome is the incidence of urethrocutaneous fistula. Secondary outcomes include perioperative opioid consumption, postoperative pain scores, analgesic duration, and other surgical complications such as wound dehiscence and urethral stricture. Patients will be followed up for 3-6 months postoperatively. The study will be conducted across four centers in Turkey. Results are expected to provide evidence-based guidance on the role of caudal block in pediatric hypospadias repair.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male patients aged 6-60 months

Diagnosed with distal hypospadias

Scheduled for elective hypospadias repair

Written informed consent obtained from parent or legal guardian

Disqualifiers

Age < 6 months or > 60 months

Proximal or non-distal hypospadias

Previous hypospadias repair

Skin lesions at the epidural/caudal injection site

Trial design

Design model

Parallel

Treatments tested in this trial

  • Caudal Block

    Procedure/Surgery

    General anesthesia combined with caudal block administered prior to distal hypospadias repair. Caudal block is performed using bupivacaine hydrochloride as part of standard institutional analgesic protocol.

  • General Anesthesia without Caudal Block

    Procedure/Surgery

    General anesthesia alone administered without caudal block for distal hypospadias repair. Intravenous analgesic agents used as per standard institutional protocol.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Group 1) Caudal Block GroupExperimental treatment 1 intervention
Group B: Group 2) Non-Caudal GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of Urethrocutaneous Fistula

Development of urethrocutaneous fistula following distal hypospadias repair, assessed by clinical examination

Time frame
up to 3 months

Secondary outcomes

1

Postoperative Pain Scores

Postoperative pain assessed using age-appropriate pain scales (e.g., Visual Analog Scale or FLACC scale, where higher scores indicate worse pain).

Time frame
Up to 24 hours postoperatively
2

Surgical Complications

Incidence of surgery-related complications

Time frame
Up to 3 months
3

Duration of Effective Analgesia

The time from the completion of the surgical/anesthetic procedure until the patient first requests or requires rescue analgesia.

Time frame
Up to 24 hours postoperatively
4

Total Consumption of Rescue Analgesics

The total amount (mg) of rescue analgesic medications required by the patient during the postoperative period.

Time frame
Up to 24 hours postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.